|
SASH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.33249999999475E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.89837999999831E-05 |
| Normal-vs-Stage2 |
5.319100E-03 |
| Normal-vs-Stage3 |
4.19720000000012E-06 |
| Normal-vs-Stage4 |
2.458500E-03 |
| Stage1-vs-Stage2 |
6.880600E-01 |
| Stage1-vs-Stage3 |
3.685200E-01 |
| Stage1-vs-Stage4 |
8.600600E-01 |
| Stage2-vs-Stage3 |
2.697800E-01 |
| Stage2-vs-Stage4 |
5.913800E-01 |
| Stage3-vs-Stage4 |
7.310400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02619999999376E-05 |
| Normal-vs-AfricanAmerican |
8.384500E-04 |
| Normal-vs-Asian |
6.87360000029003E-08 |
| Caucasian-vs-AfricanAmerican |
5.588800E-01 |
| Caucasian-vs-Asian |
2.482700E-03 |
| AfricanAmerican-vs-Asian |
2.059700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80350999999801E-05 |
| Normal-vs-Female |
7.384100E-04 |
| Male-vs-Female |
4.620000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.87520000000708E-05 |
| Normal-vs-Extreme_Weight |
4.76689999995283E-06 |
| Normal-vs-Obese |
5.239100E-03 |
| Normal-vs-Extreme_Obese |
3.81799999999988E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.737200E-01 |
| Normal_Weight-vs-Obese |
2.236800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.968800E-01 |
| Extreme_Weight-vs-Obese |
1.409190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.827200E-01 |
| Obese-vs-Extreme_Obese |
1.631690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.686800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.827600E-04 |
| Normal-vs-Age(61-80Yrs) |
4.87730000831021E-09 |
| Normal-vs-Age(81-100Yrs) |
6.620900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.227000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.044200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.524400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.346200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.134200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.2342000000013E-05 |
| Normal-VS-Type2 PRCC |
8.66839999780211E-09 |
| Normal-VS-KIRP CIMP |
7.378400E-01 |
| Normal-VS-Unclassified PRCC |
1.077580E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.120100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.510200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.617000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.181370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.952800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.411810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.35159999648371E-08 |
| Normal-vs-N1 |
3.979600E-04 |
| Normal-vs-N2 |
2.709900E-02 |
| N0-vs-N1 |
3.047400E-01 |
| N0-vs-N2 |
9.998400E-01 |
| N1-vs-N2 |
6.456600E-01 |
|
|
